| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ONCOLYTICS BIOTECH INC | Director | Common Shares | 466,991 | $484,596 | $1.04 | 16 Jan 2026 | Direct |
| Aprea Therapeutics, Inc. | Director | Common Stock | 45,775 | $74,155 | $1.62 | 05 Jun 2025 | Direct |
| Aptose Biosciences Inc. | Director | Common Shares | 17,000 | $53,380 | $3.14 | 22 Sep 2023 | Direct |
| Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 4,185 | 20 Jun 2024 | Direct | ||
| Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 4,185 | 05 Jun 2025 | Direct | ||
| Aptose Biosciences Inc. | Director | Director Stock Option (Right to Buy) | 3,333 | 05 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ONCY | ONCOLYTICS BIOTECH INC | 16 Jan 2026 | 1 | +$103,770 | 4 | Director | 20 Jan 2026, 16:30 |
| ONCY | ONCOLYTICS BIOTECH INC | 01 Jan 2026 | 0 | $0 | 3 | Director | 02 Jan 2026, 16:30 |
| APRE | Aprea Therapeutics, Inc. | 05 Jun 2025 | 2 | $0 | 4 | Director | 09 Jun 2025, 16:07 |
| APRE | Aprea Therapeutics, Inc. | 11 Oct 2024 | 1 | +$26,800 | 4 | Director | 15 Oct 2024, 08:31 |
| APRE | Aprea Therapeutics, Inc. | 20 Jun 2024 | 2 | $0 | 4 | Director | 21 Jun 2024, 16:20 |
| APRE | Aprea Therapeutics, Inc. | 13 Mar 2024 | 3 | +$50,009 | 4 | Director | 14 Mar 2024, 20:53 |
| APTOF | Aptose Biosciences Inc. | 05 Feb 2024 | 1 | $0 | 4 | Director | 07 Feb 2024, 16:56 |
| APTOF | Aptose Biosciences Inc. | 22 Sep 2023 | 1 | +$53,380 | 4 | Director | 25 Sep 2023, 18:03 |
| APRE | Aprea Therapeutics, Inc. | 23 Aug 2023 | 2 | $0 | 4 | Director | 24 Aug 2023, 22:48 |
| APRE | Aprea Therapeutics, Inc. | 06 Jun 2023 | 2 | +$36,957 | 4 | Director | 08 Jun 2023, 16:34 |
| APTOF | Aptose Biosciences Inc. | 19 Jan 2023 | 1 | $0 | 4 | Director | 23 Jan 2023, 19:03 |
| APTOF | Aptose Biosciences Inc. | 14 Sep 2022 | 1 | $0 | 4 | Director | 16 Sep 2022, 17:32 |
| APTOF | Aptose Biosciences Inc. | 13 Sep 2022 | 0 | $0 | 3 | Director | 16 Sep 2022, 17:29 |
| APRE | Aprea Therapeutics, Inc. | 28 Jul 2022 | 2 | $0 | 4 | Director | 01 Aug 2022, 17:06 |
| APRE | Aprea Therapeutics, Inc. | 18 May 2022 | 1 | +$35,500 | 4 | Director | 19 May 2022, 16:31 |
| APRE | Aprea Therapeutics, Inc. | 30 Jun 2021 | 2 | $0 | 4 | Director | 01 Jul 2021, 19:00 |